Liver and bone in tandem: osteopenia as an inevitable companion to non-alcoholic fatty liver disease DOI
А.Ф. Шептулина, A. A. Yafarova, E.M. Mamutova

et al.

Russian Journal of Evidence-Based Gastroenterology, Journal Year: 2024, Volume and Issue: 13(4), P. 40 - 40

Published: Jan. 1, 2024

Language: Английский

Inter-organ metabolic interaction networks in non-alcoholic fatty liver disease DOI Creative Commons
Yuhong Fan, Siyao Zhang, Ye Wang

et al.

Frontiers in Endocrinology, Journal Year: 2025, Volume and Issue: 15

Published: Jan. 9, 2025

Non-alcoholic fatty liver disease (NAFLD) is a multisystem metabolic disorder, marked by abnormal lipid accumulation and intricate inter-organ interactions, which contribute to systemic imbalances. NAFLD may progress through several stages, including simple steatosis (NAFL), non-alcoholic steatohepatitis (NASH), cirrhosis, potentially cancer. This closely associated with disorders driven overnutrition, key pathological processes dysregulation, impaired autophagy, mitochondrial dysfunction, endoplasmic reticulum (ER) stress, local inflammation. While hepatic metabolism in well-documented, further research into communication mechanisms crucial for deeper understanding of progression. review delves intrahepatic networks tissue-specific signaling mediators involved pathogenesis, emphasizing their impact on distal organs.

Language: Английский

Citations

1

Risk factors for decreased bone mineral density in patients with metabolic dysfunction-associated steatotic liver disease: A cross-sectional study at a health examination center DOI Creative Commons
Shinya Yokoyama, Takashi Honda, Yoji Ishizu

et al.

Clinical Nutrition, Journal Year: 2024, Volume and Issue: 43(6), P. 1425 - 1432

Published: April 29, 2024

Background & Aims Steatotic liver disease (SLD) is often detected in health examinations. However, although individuals with metabolic dysfunction-associated SLD (MASLD) may have decreased bone mineral density (BMD), the specific risk factors remain unclarified. The objective of this study was to identify associated BMD patients MASLD. Methods Individuals who underwent abdominal ultrasonography and measurements at our healthcare center were included. calcaneus assessed using an AOS-10SA densitometer. Decreased defined as a T-score below -1.0 SD or administration osteoporosis treatment. diagnosed based on ultrasonographic criteria. Results A total 1,410 median age 52 years. Multivariate analysis logistic regression model revealed that independent predictors low body mass index (BMI) small waist circumference (odds ratio (OR): 0.48, 95% confidence interval (CI): 0.34–0.67), hypertriglyceridemia (OR: 1.29, CI: 1.00–1.65), weak grip strength 0.98, 0.97–1.00). Subgroup analyses aged 50 years older, men, FIB-4 1.3 greater absence high BMI large BMD. subgroup men weaker Conclusion present suggested several potential for abovementioned should be encouraged undergo measurement from perspective preventive medicine.

Language: Английский

Citations

5

Associations of metabolic dysfunction-associated fatty liver disease and hepatic fibrosis with bone mineral density and risk of osteopenia/osteoporosis in T2DM patients DOI Creative Commons
Wei Zhang, Yuhua Li,

Shangjian Li

et al.

Frontiers in Endocrinology, Journal Year: 2023, Volume and Issue: 14

Published: Dec. 4, 2023

Background Existing evidence on the associations of liver steatosis and fibrosis with bone mineral density (BMD) risk osteopenia/osteoporosis was limited conflicting results. We aimed to evaluate metabolic dysfunction-associated fatty disease (MAFLD) hepatic BMD in type 2 diabetes mellitus (T2DM) patients. Methods Baseline information an ongoing cohort 249 T2DM patients Xiamen, China analyzed. MAFLD defined as presence [diagnosed by either ultrasonography scanning or index (FLI) score >60] for measured using dual-energy x-ray absorptiometry at total lumbar (L2–4), femur neck (FN), hip (TH) categorized normal (T ≥ −1.0), osteopenia (−2.5 < T osteoporosis ≤ −2.5) according its minimum T-score. Results Among patients, prevalence rates MAFLD, osteopenia, were 57.8%, 50.6%, 17.7%, respectively. Patients had significantly higher T-scores L2–4, FN, TH well lower than without MAFLD. Hepatic indices, including FLI score, (FLI 60 scanning), positively associated all T-scores, while FIB-4 but not NAFLD (NFS), negatively T-scores. decreased unadjusted odds ratios (ORs) (95% CI) 0.565 (0.324–0.987) 0.434 (0.224–0.843) (both p -values 0.05), As fibrosis, NFS, elevated OR per SD increase 1.446 (1.080–1.936, -value = 0.013). Adjusting potential confounding variables, especially body mass index, multivariable regression analyses, indices statistically significant. Conclusion independent obesity. Nevertheless, screening management still important prevention fracture

Language: Английский

Citations

12

Association of chronic liver disease with bone diseases and muscle weakness DOI
Chisato Saeki, Mitsuru Saito, Akihito Tsubota

et al.

Journal of Bone and Mineral Metabolism, Journal Year: 2024, Volume and Issue: 42(4), P. 399 - 412

Published: Feb. 1, 2024

Language: Английский

Citations

4

The relationship between advanced liver fibrosis and osteoporosis in type 2 diabetes patients with MAFLD DOI

Binjing Pan,

Yangting Zhao,

Chongyang Chen

et al.

Endocrine, Journal Year: 2024, Volume and Issue: 85(1), P. 206 - 221

Published: Feb. 17, 2024

Language: Английский

Citations

4

Effects of Metabolic Dysfunction-Associated Steatotic Liver Disease on Bone Density and Fragility Fractures: Associations and Mechanisms DOI Creative Commons
Shaghayegh Khanmohammadi, Mohammad Shafi Kuchay

Journal of Obesity & Metabolic Syndrome, Journal Year: 2024, Volume and Issue: 33(2), P. 108 - 120

Published: May 14, 2024

Metabolic dysfunction-associated steatotic liver disease (MASLD) has profound adverse effects on bone health and homeostasis. MASLD appears to be associated with changes in mineral density (BMD) fracture rate. However, the data are ambiguous conflicting. Although several studies have shown that children adolescents decreased BMD, prevalence of fragility fractures among scarce. In adults, increasing evidence suggests decreases BMD increases risk fractures, which due deterioration architecture addition a decrease BMD. Effects may also age- race-specific. does not seem increase but elderly men, especially those Asian origin. From mechanistic perspective, remodeling is continuous process between osteoblasts (bone-forming) osteoclasts (bone-resorbing), any imbalance resulting metabolic disease. individuals MASLD, loss anabolic insulin receptor signaling (insulin resistance) increased activator nuclear factor κB (RANK)/RANK ligand (proinflammatory cytokines) swings pendulum toward accelerated loss. These processes further complicated by concomitant presence obesity, type 2 diabetes mellitus, or sarcopenia MASLD. This study reviews current literature children/adolescents adults. review discusses pathomechanisms link fractures.

Language: Английский

Citations

4

Association between liver fibrosis and osteoporosis in adults aged 50 and older: insights from the Bushehr Elderly Health Program DOI
Akbar Soltani, Amirhossein Aghakhani, Hojat Dehghanbanadaki

et al.

Journal of Diabetes & Metabolic Disorders, Journal Year: 2025, Volume and Issue: 24(1)

Published: Feb. 6, 2025

Language: Английский

Citations

0

Multifaceted environmental factors linked to metabolic dysfunction-associated fatty liver disease: an environment-wide association study DOI Creative Commons
Rui Dong, Ting Tian, Ming Chen

et al.

BMC Public Health, Journal Year: 2025, Volume and Issue: 25(1)

Published: Feb. 20, 2025

Environmental factors, or exposome, are non-negligible contributors to the occurrence and progression of metabolic dysfunction-associated fatty liver disease (MAFLD). Therefore, this environment-wide association study (EWAS) aimed investigate associations between multifarious environmental factors MAFLD among general adult population in United States. Eligible participants were obtained from National Health Nutrition Examination Survey 2005-2020 cycles. Survey-weighted multivariate logistic regression models constructed identify tentatively validate MAFLD-associated factors. The least absolute shrinkage selection operator (LASSO) was conducted validated with stronger MAFLD. Moreover, importance, discrimination power, correlation patterns, subgroup-specific differences, survey cycle heterogeneity identified further examined by multiple statistical strategies. A total 14,416 included EWAS. Among 511 candidate 167 validated, 45 preserved after LASSO evaluation. In study, most previously known replicated reduced bias, several poorly studied discovered, for example, upper leg length, access care, mid-upper arm circumference, trabecular bone score. Their ability, pairwise correlations, subgroup variations, across cycles systematically rigorously evaluated. This EWAS comprehensively explored a panoramic perspective. findings may provide clues understanding promote early prevention risk prediction strategies future.

Language: Английский

Citations

0

Genetic evidence of the causal relationship between chronic liver diseases and musculoskeletal disorders DOI Creative Commons

Zhengjie Lu,

Xuefei Li, Yongjian Qi

et al.

Journal of Translational Medicine, Journal Year: 2024, Volume and Issue: 22(1)

Published: Feb. 6, 2024

Abstract Background Chronic liver diseases constitute a major global public health burden, posing substantial threat to patients’ daily lives and even survival due the potential development of musculoskeletal disorders. Although relationship between chronic disorders has received extensive attention, their causal not been comprehensively systematically investigated. Methods This study aimed assess relationships viral hepatitis, primary biliary cholangitis, sclerosing cholangitis (PSC), cirrhosis, hepatocellular carcinoma (HCC) with osteoporosis, osteoarthritis, sarcopenia through bidirectional Mendelian randomization (MR) research. The traits related osteoporosis osteoarthritis included both overall site-specific phenotypes, linked involved indicators muscle mass function. Random-effect inverse-variance weighted (IVW), median, MR-Egger, Causal Analysis Using Summary Effect Estimates were used evaluate effects, IVW being main analysis method. To enhance robustness, sensitivity analyses performed using Cochran’s Q test, MR-Egger intercept, MR-PRESSO funnel plots, leave-one-out analyses, latent variable model. Results forward MR indicated that PSC can reduce forearm bone mineral density (beta = − 0.0454, 95% CI 0.0798 0.0110; P 0.0098) increase risk (OR 1.012, 1.002–1.022; 0.0247), while HCC decrease grip strength 0.0053, 0.008 0.0025; 0.0002). reverse did find significant effects on diseases. Additionally, no heterogeneity or pleiotropy was detected. Conclusions These findings corroborate as well impact sarcopenia. Thus, implementation comprehensive preventive measures is imperative for patients mitigate disorders, ultimately improving quality life.

Language: Английский

Citations

3

Metabolic dysfunction–associated fatty liver disease and osteoporosis: the mechanisms and roles of adiposity DOI
Jie Tao,

Hong Li,

Honggang Wang

et al.

Osteoporosis International, Journal Year: 2024, Volume and Issue: 35(12), P. 2087 - 2098

Published: Aug. 13, 2024

Language: Английский

Citations

3